An Open-Label, Multicenter, Phase 1 Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Ascending Intravenous Doses of Inhibrx rhAAT-Fc (INBRX-101) in Adults with Alpha-1 Antitrypsin Deficiency (AATD)

Study on Safety and Tolerability of Investigational Medication for Alpha-1 Antitrypsin Deficiency (AATD)

Recruiting
18 years - 70 years
All
1 Location

Brief description of study.

The purpose of the study is to assess safety and tolerability of a Phase I drug, INBRX-101 in patients with alpha-1 antitrypsin deficiency (AATD).

Detailed description of study

Here at IU Health, we are recruiting for clinical trial to study the effects of a new drug on Alpha-1 Antitrypsin Deficiency (AATD).  All study procedures will take place at University Hospital at no cost to you.  You will be compensated for your time and effort.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Alpha-1 Antitrypsin Deficiency (AATD)
  • Age: 18 years - 70 years
  • Gender: All

Inclusion Criteria

AATD diagnosis, willing to undergo 2 bronchoscopies

Non-smoker

Willing to hold current AATD treatment until study ends (about 5 months).

Updated on 19 Feb 2024. Study ID: 1902734320

This study investigates the safety and tolerability of an investigational medication in patients with Alpha-1 Antitrypsin Deficiency (AATD). AATD is a genetic condition that can cause lung and liver problems. The purpose of this study is to understand how the investigational medication affects individuals with this condition.

Participants will undergo procedures such as bronchoscopies, which involve using a thin tube to look inside the lungs. All study procedures will take place at University Hospital, and participants will receive compensation for their time and effort.

  • Who can participate: Adults diagnosed with Alpha-1 Antitrypsin Deficiency who are non-smokers and willing to undergo 2 bronchoscopies can participate. Participants must be willing to pause their current AATD treatment for about 5 months.
  • Study details: Participants will take part in study procedures at University Hospital, including undergoing bronchoscopies. A bronchoscopy is a procedure that uses a thin tube to examine the lungs. Participants will be compensated for their time and effort.

Find a site

Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact label
Race
Ethnicity
Other language

Default Content Message Here